Ipsen at a glance

Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.6 billion in 2016. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries worldwide. The Group has more than 5,100 employees all over the world.

SH-ipsen-group
Alimos-office-1024x683-2

Ipsen in Greece

Our presence in Greece dates back from 1979.

Strategy

Our strategy is to build a global biopharma company focused on innovation and specialty care which delivers differentiated therapeutics to meet unmet patient needs.

ipsen-strategie
Ipsen-historique

History

Since it was founded in 1929, by Henri Beaufour, Ipsen has developed, and made available to patients, a number of products in Oncology, Neuroscience, Rare Diseases and Consumer Healthcare. Global footprint, acquisitions, partnerships, scientific collaborations and innovations: learn about the development of our group over the years.

Locations

Ipsen is firmly anchored in the international market with a direct commercial presence in more than 30 countries. Use our interactive map to find information on our locations around the world.

SH-locations
Last update 17/07/2018